Suzanne Bujara

Researchers found data that show adverse lifestyle factors increase the risk for depression.

Researcher data showed that the boundaries to successful treatment in depression in patients who are minorities are varied, but that there are certain predisposing factors such as adverse childhood events and genetics.

Researchers found data to support their hypothesis that developmental stress vulnerability is the link between a predisposition and environmental triggers in the pathophysiology of schizophrenia.

Researchers found a small number of clinical trials that indicated antidepressant effects of cytokine blockers.

Researchers found that the inclusion of significant others in cognitive behavioral therapy for victims of violent crimes is beneficial for the victim and indirect victim.

Researchers found no association between depression severity and brain-derived neurotrophic factor (BDNF) levels, and no correlation between BDNF levels and response to electroconvulsive therapy.

Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.

The European Medicine Agency has reported that there may be an association between long-term lithium use and reports of both renal tumors and thyroid cancer.

Given the substantial burden of nonadherence to therapy in patients with schizophrenia, new interventions for compliance are critical.

As depression is one of the most common psychiatric disorders following acute stroke and can be predictive of poor outcomes, identifying biomarkers to recognize the disorder are imperative for improving the clinical course.